O morbo de Alzheimer o l'é un desordine neurològico progrescivo ch'o fa che e çellole do çervello se degeneran e moan, con portâ à un declin da memöia, do pensceo e de capaçitæ de raxonamento.
A l'é a caxon ciù commun de demensa, ch'a rappresenta o 60-80% de tutti i caxi.
A mouttia a l'é pe-o ciù fatale, con unn'aspettativa de vitta media dòppo a diagnosi de 4-8 anni, sciben che çerte persoñe peuan vive fin à 20 anni con a mouttia.
O tascio de mortalitæ pe-a mouttia de Alzheimer o cangia à segonda de l'analixi e da popolaçion examinâ.
Segondo l'Associaçion Alzheimer, a mouttia de Alzheimer a l'é a sesta caxon de mòrte inti Stati Unii, e a l'é a quinta caxon de mòrte pe quelli de 65 anni e ciù.
Do 2019, a mouttia de Alzheimer a l'é stæta segnalâ comme a caxon de mòrte de 121.9444 persoñe inti Stati Unii.
L'é importante notâ che o tascio de mortalitæ pe-a mouttia de Alzheimer o no l'é dovuo solo a-a mouttia mæxima, ma ascì a-e complicaçioin e à di atri problemi de sanitæ che ne vëgnan.
Quande a mouttia a progredisce, i individui peuan avei de difficoltæ co-e attivitæ da vitta de tutti i giorni, comme mangiâ, bagnâse e vestîse, che peuan portâ à desnutriçion, infeçioin e atri problemi de sanitæ.
Pe de ciù, i individui con a mouttia de Alzheimer peuan ëse à ciù erco de cheite, pneumonia e atre infeçioin.
Sciben che a-o momento no gh'é unna mëxiña pe-a mouttia de Alzheimer, gh'é de terapie che peuan aggiuttâ à gestî i scintomi e megioâ a qualitæ da vitta.
A reçerca a l'é apreuvo à sviluppâ de neuve terapie e in sciâ fin attrovâ unna mëxiña pe sta mouttia devastante.
Zhu B, Chen X, Li W, Zhou D: Effect of Alzheimer Disease on Prognosis of Intensive Care Unit (ICU) Patients: A Propensity Score Matching Analysis. Med Sci Monit. 2022, 28 (): e935397.
Almeida MC, Gomes Cde M, Nascimento LF: Spatial distribution of deaths due to Alzheimer's disease in the state of São Paulo, Brazil. Sao Paulo Med J. 2014, 132 (4): 199-204.
Aevarsson O, Svanborg A, Skoog I: Seven-year survival rate after age 85 years: relation to Alzheimer disease and vascular dementia. Arch Neurol. 1998, 55 (9): 1226-32.
Breitner JC: Clinical genetics and genetic counseling in Alzheimer disease. Ann Intern Med. 1991, 115 (8): 601-6.
Iulita MF, Garzón Chavez D, Klitgaard Christensen M, Valle Tamayo N, Plana-Ripoll O, Rasmussen SA, Roqué Figuls M, Alcolea D, Videla L, Barroeta I, Benejam B, Altuna M, Padilla C, Pegueroles J, Fernandez S, Belbin O, Carmona-Iragui M, Blesa R, Lleó A, Bejanin A, Fortea J: Association of Alzheimer Disease With Life Expectancy in People With Down Syndrome. JAMA Netw Open. 2022, 5 (5): e2212910.
['Disclaimer: medicâ']
["Sto scito web o l'é fornio solo pe di propòxiti educativi e informativi e o no costituisce un conseggio medico ò serviççi profescionæ."]
["L'informaçion fornia a no dovieiva ëse deuviâ pe diagnosticâ ò curâ un problema de sanitæ ò unna mouttia, e quelli che çercan un conseggio medico personale devan consultâ un mego licençiou."]
['Pe piaxei, ti ti o sæ che a ræ neurale ch\'a genera de respòste a-e domande a l"é inprecisa sorviatutto quande se tratta de contegnui numerichi, comme o numero de persoñe che gh\'é stæto diagnosticou unna mouttia particolâ.']
["çercâ delongo o conseggio do teu mego ò de un atro fornitô de sanitæ qualificou in sciâ condiçion medica. no trascurâ mai o conseggio de un mego profescionista ò ritardâ a çercâlo apreuvo à quarcösa che ti t'æ lezuo in sce sto scito web."]
['Disclaimer: copyright']
["O Digital Millennium Copyright Act do 1998, 17 U.S.C. § 512 (o DMCA) o fornisce un ricorso pe-i propietäi de copyright che creddan che o materiale ch'o l'appare in sce Internet o l'infrange i seu driti segondo a leze di copyright di Stati Unii. "]
["Se ti ti creddi de bonn-a fede che un qualunque contegnûo ò materiale misso a dispoxiçion in connescion co-o nòstro scito web ò serviççi o l'infrange i teu driti d'autô, ti (ò o teu agente) ti peu mandâne 'na notifica con domandâ che o contegnûo ò o materiale o segge levòu ò che l'acesso o segge bloccou."]
['E comunicaçioin devan vegnî mandæ pe iscritto pe email (veddi a seçion "Contact" pe l\'indirissô email).']
["O DMCA o l'exige che a teu notifica de presunta violaçion di driti d'autô a contégne e informaçioìn chi sótta: (1) descriçion de l'euvia protetta da driti d'autô ch'a l'é l'oggetto da presunta violaçion; (2) descriçion do contegnûo che se presumibilmente o l'é a violaçion e informaçioìn suffiçienti pe permette a niatri de localizzâlo; (3) informaçioìn de contatto pe ti, compreiso o teu indirìsso, o teu nómme de telefonin e o teu indirìsso email; (4) 'na teu affermaçion che ti ti credi de bonn-a fêde che o contegnûo into mòddo reclamòu o no segge autorizòu da-o propietâio di driti d'autô, ò da-o seu agente, ò da l'açion de quæ se segge leze; "]
["(5) unna declaraçion da parte teu, firmâ sotta pena de perjurio, che e informaçioin inta notifica son accuræ e che ti gh'æ l'autoritæ de fâ respettâ i driti d'autô che se sostegne che seggian stæti violati;"]
["e (6) unna firma fixica ò elettrònica do propietäio do drito d'autô ò de unna persoña autorisâ à agî a-o seu nomme."]
["Se no ti inserisci tutte e informaçioin chì de d'ato, o peu comportâ un retardo into trattamento da teu lamentela."]
['Contatto']
["Pe piaxei manda 'na mail con ògni domanda/suggerimento."]
How deadly is alzheimer?
Alzheimer's disease is a progressive neurological disorder that causes brain cells to degenerate and die, leading to a decline in memory, thinking, and reasoning skills.
It is the most common cause of dementia, accounting for 60-80% of all cases.
The disease is ultimately fatal, with the average life expectancy after diagnosis being 4-8 years, although some people can live up to 20 years with the disease.
The mortality rate for Alzheimer's disease varies depending on the study and the population being examined.
According to the Alzheimer's Association, Alzheimer's disease is the sixth leading cause of death in the United States, and it is the fifth leading cause of death for those aged 65 and older.
In 2019, Alzheimer's disease was reported as the underlying cause of death for 121,9444 people in the United States.
It is important to note that the mortality rate for Alzheimer's disease is not solely due to the disease itself, but also due to complications and other health issues that arise as a result of the disease.
As the disease progresses, individuals may experience difficulty with activities of daily living, such as eating, bathing, and dressing, which can lead to malnutrition, infections, and other health problems.
Additionally, individuals with Alzheimer's disease may be at an increased risk of falls, pneumonia, and other infections.
While there is currently no cure for Alzheimer's disease, there are treatments available that can help manage symptoms and improve quality of life.
Research is ongoing to develop new treatments and ultimately find a cure for this devastating disease.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['In sciâ']
['BioMedLib o deuvia di computer automatizzæ (algoritmi de machine learning) pe generâ de cobbie de domande e respòste.']
['Comensemmo con 35 mioin de pubricaçioin biomediche de PubMed/Medline.']
